Pfizer

Pfizer To Exit GSK's Consumer Health Arm After London Listing

Pfizer plans to exit its 32% stake in Haleon, a consumer health joint venture with British drugmaker GSK, after the business lists as an independent c...

GSK Rejects Activist Elliott's Demands For Board And Consumer Business

GSK's board on Friday rejected Elliott's demands that the British company change its board and sell its consumer healthcare arm after separating it from it...

Pfizer Ends COVID-19 Trial With 95% Efficacy

Pfizer Inc said that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, adding it had the required two-months of sa...

Pfizer Says COVID-19 Vaccine 'Over 90% Effective', Markets Surge

Pfizer Inc has said that its experimental COVID-19 vaccine is more than 90% effective, a major victory in the fight against a pandemic that has k...

GSK Buys 10% Of CureVac In Vaccine Tech Deal

GSK is to buy a 10% stake in German biotech company CureVac for £130 million ($163.67 million), the two companies said on Monday, in a deal that...

GSK And Pfizer Complete Consumer Healthcare Joint Venture

GlaxoSmithKline (GSK) and Pfizer have announced the closing of the joint venture that will combine the companies’ respective consumer healthcare busi...

GSK To Split Into Two Businesses After Striking Pfizer Consumer Health Deal

GlaxoSmithKline plans to split into two businesses - one for prescription drugs and vaccines, the other for over-the-counter products - after forming a new...

Subscribe Today

ABOUT US

Get the app today!